Artiva Biotherapeutics, Inc. (ARTV) insider trading.
In Q3 2026, insiders at Artiva Biotherapeutics, Inc. reported 26 non-derivative transactions on 33 Forms 3, 4 and 5: 11 open-market purchases worth $5.1M and 7 sales worth $1.3M.
- Transactions
- 26
- Purchases (P)
- 11
- Sales (S)
- 7
- Net shares, P minus S
- 426,378
- Insiders
- 10
- Last filed
- 2026-09-15
Insiders
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Aslan Fred | A (A) | 110,000 | $0 | 1,604,765 | Form 4 |
| 2026-09-10 | Aslan Fred | A (A) | 45,000 | $0 | 1,494,765 | Form 4 |
| 2026-09-09 | Banerjee Subhashis | A (A) | 30,000 | $0 | 170,947 | Form 4 |
| 2026-09-09 | Bush Jennifer | A (A) | 45,000 | $0 | 374,529 | Form 4 |
| 2026-09-09 | Horan Christopher | A (A) | 40,000 | $0 | 323,084 | Form 4 |
| 2026-09-09 | Miralles Gines Diego | A (A) | 45,000 | $0 | 122,500 | Form 4 |
| 2026-09-08 | Aslan Fred | S (D) | 23,429 | $10.92 | 1,449,765 | Form 4 |
| 2026-09-03 | Aslan Fred | S (D) | 61,888 | $11.16 | 1,473,194 | Form 4 |
| 2026-09-03 | Banerjee Subhashis | S (D) | 1,100 | $11.16 | 140,947 | Form 4 |
| 2026-09-03 | Bush Jennifer | S (D) | 8,391 | $11.16 | 329,529 | Form 4 |
| 2026-09-03 | Horan Christopher | S (D) | 10,366 | $11.16 | 283,084 | Form 4 |
| 2026-08-27 | Banerjee Subhashis | M (A) | 5,306 | $1.92 | 150,269 | Form 4 |
| 2026-08-27 | Banerjee Subhashis | S (D) | 8,222 | $12.01 | 142,047 | Form 4 |
| 2026-08-18 | Banerjee Subhashis | S (D) | 429 | $12 | 144,963 | Form 4 |
| 2026-08-18 | Banerjee Subhashis | M (A) | 429 | $1.92 | 145,392 | Form 4 |
| 2026-07-31 | RA Capital Healthcare Fund LP / Shah Rajeev M. / RA Capital Nexus Fund III, L.P. / Kolchinsky Peter / RA Capital Nexus Fund, L.P. / RA CAPITAL MANAGEMENT, L.P. | P (A) | 24,944 | $9.93 | 17,329,570 | Form 4 |
| 2026-07-29 | RA Capital Healthcare Fund LP / Shah Rajeev M. / RA Capital Nexus Fund III, L.P. / Kolchinsky Peter / RA Capital Nexus Fund, L.P. / RA CAPITAL MANAGEMENT, L.P. | P (A) | 20,824 | $9.99 | 17,304,626 | Form 4 |
| 2026-07-24 | RA Capital Nexus Fund III, L.P. / Kolchinsky Peter / RA Capital Nexus Fund, L.P. / RA CAPITAL MANAGEMENT, L.P. / Shah Rajeev M. / RA Capital Healthcare Fund LP | P (A) | 41,319 | $9.99 | 17,283,802 | Form 4 |
| 2026-07-23 | Kolchinsky Peter / RA Capital Nexus Fund, L.P. / RA Capital Nexus Fund III, L.P. / Shah Rajeev M. / RA Capital Healthcare Fund LP / RA CAPITAL MANAGEMENT, L.P. | P (A) | 59,880 | $9.96 | 17,242,483 | Form 4 |
| 2026-07-22 | Kolchinsky Peter / RA Capital Nexus Fund, L.P. / RA Capital Nexus Fund III, L.P. / Shah Rajeev M. / RA Capital Healthcare Fund LP / RA CAPITAL MANAGEMENT, L.P. | P (A) | 84,124 | $9.93 | 17,182,603 | Form 4 |
| 2026-07-21 | Kolchinsky Peter / RA Capital Nexus Fund, L.P. / RA Capital Nexus Fund III, L.P. / Shah Rajeev M. / RA Capital Healthcare Fund LP / RA CAPITAL MANAGEMENT, L.P. | P (A) | 120,582 | $9.55 | 17,098,479 | Form 4 |
| 2026-07-17 | RA Capital Healthcare Fund LP / RA Capital Nexus Fund, L.P. / RA Capital Nexus Fund III, L.P. / RA CAPITAL MANAGEMENT, L.P. / Kolchinsky Peter / Shah Rajeev M. | P (A) | 7,882 | $8.95 | 16,977,927 | Form 4 |
| 2026-07-16 | RA Capital Healthcare Fund LP / RA Capital Nexus Fund, L.P. / RA Capital Nexus Fund III, L.P. / RA CAPITAL MANAGEMENT, L.P. / Kolchinsky Peter / Shah Rajeev M. | P (A) | 152,472 | $8.93 | 16,970,045 | Form 4 |
| 2026-07-13 | RA Capital Nexus Fund, L.P. / RA CAPITAL MANAGEMENT, L.P. / RA Capital Nexus Fund III, L.P. / Shah Rajeev M. / Kolchinsky Peter / RA Capital Healthcare Fund LP | P (A) | 6,522 | $8.94 | 16,817,543 | Form 4/A |
| 2026-07-13 | Shah Rajeev M. / RA Capital Nexus Fund, L.P. / RA Capital Healthcare Fund LP / RA Capital Nexus Fund III, L.P. / RA CAPITAL MANAGEMENT, L.P. / Kolchinsky Peter | P (A) | 6,552 | $8.94 | 16,817,573 | Form 4 |
| 2026-07-10 | Shah Rajeev M. / RA Capital Nexus Fund, L.P. / RA Capital Healthcare Fund LP / RA Capital Nexus Fund III, L.P. / RA CAPITAL MANAGEMENT, L.P. / Kolchinsky Peter | P (A) | 15,102 | $8.97 | 16,811,021 | Form 4 |
Transaction codes in this quarter
Get ARTV insider transactions through the API
Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1817241&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · ARTV company page · Artiva Biotherapeutics, Inc. on SEC.gov
Questions
Are insiders buying or selling Artiva Biotherapeutics, Inc. (ARTV)?
In Q3 2026, insiders at Artiva Biotherapeutics, Inc. reported 26 non-derivative transactions on 33 Forms 3, 4 and 5: 11 open-market purchases worth $5.1M and 7 sales worth $1.3M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Artiva Biotherapeutics, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.
Plain-text version for agents and LLMs: /insider-trading/artv.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.